A multidisciplinary team of specialists involved in caring for patients with chronic myeloid leukaemia (CML) and a patient advocate share their insights on the later-line treatment of CML.

They discuss treatment options, side effects and strategies to maximize the quality of life for patients.

Watch now: [ Ссылка ]

This activity is funded by an independent medical education grant from Novartis. This activity is provided by touchIME.

свернуть